We are 29,000 people focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts. We also are parents, brothers, sisters, friends, community leaders, volunteers, and more. We have a lot in common with the people we serve, and we come together every day to create, discover, and deliver new ways to improve people's health.
What We Do
We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
We remember that, as healthcare grows ever more complex, the onus is on us to ensure our medicines understood by those that use them. We add value and get the best outcomes through the education, services and support we provide beyond our medicines. In the UK, we are supporting care closer to home and patient self-management through practical programmes that are fully attuned to NHS England policy.
Research and innovation are the cornerstones of our business. We advance leading-edge science through a dynamic and collaborative approach. This enables us to find better solutions for treating the world’s most challenging diseases. We focus on discovering, developing and delivering drugs in therapeutic areas where we have proven expertise—and can make an impact.
This includes:
- Immunology
- Oncology
- Neuroscience
- Virology
- General Medicine
Our Promise
To understand the patient journey, we collaborate with peers, academics, clinical experts, front-line NHS professionals, governments and advocacy groups. This fuels us to develop and deliver new sustainable healthcare solutions that truly make a difference to patient outcomes and experience.
